BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 22, 2011
View Archived Issues
Expanded data presented from ORACAL trial of oral versus nasal salmon calcitonin
Read More
Study identifies SNPs linked to remission and response to bupropion and placebo for depression
Read More
Orexigen receives design requirements from FDA for cardiovascular outcomes trial of Contrave
Read More
Results presented from ENCORE 301 study of exemestane plus entinostat in advanced breast cancer
Read More
Bristol-Myers Squibb and Ono enter agreement for Orencia and BMS-936558/ONO-4538
Read More
Findings disclosed from post hoc subanalysis of SYNCHRONY study
Read More
Cyclic lipopeptide shows promise to treat CDI-associated diarrhea in phase II trial
Read More
New phase I data disclosed on Pennvax-B HIV vaccine plus Genevax-IL12
Read More
European Commission approves Orion's sedative dexdor
Read More
Promising results reported on ProtoKinetix antiaging glycopeptide
Read More
Enrollment begins in phase III TOviTO program
Read More
OX-219 shows promise in patients with opioid dependence
Read More
European Commission approves Incivo
Read More
University of Pittsburgh presents new anticancer agents
Read More
ARIAD Pharmaceuticals advances phase I/II AP-26113 trial
Read More
Boehringer Ingelheim discloses novel Mnk inhibitors
Read More
Novel anticancer furoxan derivatives synthesized
Read More
New histone deacetylase inhibitors prepared by Millennium Pharmaceuticals
Read More
Aragon Pharmaceuticals describes new androgen receptor ligands
Read More
Nihon Medi-Physics begins phase III trial of imaging agent NMA-78
Read More
Repros Therapeutics' study of low-dose oral Proellex advances
Read More
Ariel Pharmaceuticals in-licenses lead product for acute migraine from BTG
Read More
Trident Pharmaceuticals' HF-1020 enters first-in-human trial
Read More
MSD launches Cubicin in Japan
Read More
European orphan drug designation granted to Pfizer's TB product candidate
Read More
F-647 approved in China
Read More